Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID | ||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
KIT [1] KIT 💬Acute myeloid leukemia
|
Imatinib mesylate Imatinib mesylate 💬Acute myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||
2 | Acute myeloid leukemia 💬 18 genes, 37 drugs (DrugBank) and 71 diseases |
KIT [1] KIT 💬Acute myeloid leukemia
|
Imatinib Imatinib 💬Acute myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬1. Acute myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||
3 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Adrenergic signaling in cardiomyocytes
| Diltiazem | 051 [4] 51, 58, 86, 88 💬3. Adrenergic signaling in cardiomyocytes |
||||||||||||||||||||||||||||||||||||||||||||||||||
4 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Adrenergic signaling in cardiomyocytes
| Diltiazem | 051 [4] 51, 58, 86, 88 💬3. Adrenergic signaling in cardiomyocytes |
||||||||||||||||||||||||||||||||||||||||||||||||||
5 | Adrenergic signaling in cardiomyocytes 💬 31 genes, 84 drugs (DrugBank) and 76 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Adrenergic signaling in cardiomyocytes
| Diltiazem | 051 [4] 51, 58, 86, 88 💬3. Adrenergic signaling in cardiomyocytes |
||||||||||||||||||||||||||||||||||||||||||||||||||
6 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Aldosterone synthesis and secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬6. Aldosterone synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
7 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Aldosterone synthesis and secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬6. Aldosterone synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
8 | Aldosterone synthesis and secretion 💬 20 genes, 41 drugs (DrugBank) and 61 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Aldosterone synthesis and secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬6. Aldosterone synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
9 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Alzheimer disease
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
10 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Alzheimer disease
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
11 | Alzheimer disease 💬 59 genes, 132 drugs (DrugBank) and 129 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Alzheimer disease
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
12 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Amphetamine addiction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬12. Amphetamine addiction |
||||||||||||||||||||||||||||||||||||||||||||||||||
13 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem malate Diltiazem malate 💬Amphetamine addiction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬12. Amphetamine addiction |
||||||||||||||||||||||||||||||||||||||||||||||||||
14 | Amphetamine addiction 💬 25 genes, 58 drugs (DrugBank) and 92 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem Diltiazem 💬Amphetamine addiction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬12. Amphetamine addiction |
||||||||||||||||||||||||||||||||||||||||||||||||||
15 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin calcium Atorvastatin calcium 💬AMPK signaling pathway
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬15. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
16 | AMPK signaling pathway 💬 16 genes, 56 drugs (DrugBank) and 95 diseases |
HMGCR [1] HMGCR 💬AMPK signaling pathway
|
Atorvastatin Atorvastatin 💬AMPK signaling pathway
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬15. AMPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
17 | Arrhythmogenic right ventricular cardiomyopathy 💬 15 genes, 30 drugs (DrugBank) and 28 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Arrhythmogenic right ventricular cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬17. Arrhythmogenic right ventricular cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
18 | Arrhythmogenic right ventricular cardiomyopathy 💬 15 genes, 30 drugs (DrugBank) and 28 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Arrhythmogenic right ventricular cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬17. Arrhythmogenic right ventricular cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
19 | Arrhythmogenic right ventricular cardiomyopathy 💬 15 genes, 30 drugs (DrugBank) and 28 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Arrhythmogenic right ventricular cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬17. Arrhythmogenic right ventricular cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
20 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib mesylate Imatinib mesylate 💬Axon guidance
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬20. Axon guidance
|
||||||||||||||||||||||||||||||||||||||||||||||||||
21 | Axon guidance 💬 22 genes, 26 drugs (DrugBank) and 75 diseases |
ABL1 [1] ABL1 💬Axon guidance
|
Imatinib Imatinib 💬Axon guidance
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬20. Axon guidance
|
||||||||||||||||||||||||||||||||||||||||||||||||||
22 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin calcium Atorvastatin calcium 💬Bile secretion
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
23 | Bile secretion 💬 14 genes, 36 drugs (DrugBank) and 61 diseases |
HMGCR [1] HMGCR 💬Bile secretion
|
Atorvastatin Atorvastatin 💬Bile secretion
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬22. Bile secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
24 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
KIT [1] KIT 💬Breast cancer
|
Imatinib mesylate Imatinib mesylate 💬Breast cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬24. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
25 | Breast cancer 💬 22 genes, 63 drugs (DrugBank) and 80 diseases |
KIT [1] KIT 💬Breast cancer
|
Imatinib Imatinib 💬Breast cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬24. Breast cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
26 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Calcium signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬26. Calcium signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
27 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Calcium signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬26. Calcium signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
28 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Calcium signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬26. Calcium signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
29 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [1] EDNRA 💬Calcium signaling pathway
|
Ambrisentan Ambrisentan 💬Calcium signaling pathway
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬29. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
30 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
31 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Calcium signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬30. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
32 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Calcium signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬32. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
33 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PDGFRA [1] PDGFRA 💬Calcium signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬Calcium signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬33. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
34 | Calcium signaling pathway 💬 86 genes, 214 drugs (DrugBank) and 143 diseases |
PDGFRA [1] PDGFRA 💬Calcium signaling pathway
|
Imatinib Imatinib 💬Calcium signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬33. Calcium signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
35 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬cAMP signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬35. cAMP signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
36 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬cAMP signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬35. cAMP signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
37 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬cAMP signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬35. cAMP signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
38 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Ambrisentan Ambrisentan 💬cAMP signaling pathway
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬38. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
39 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬39. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
40 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Bosentan Bosentan 💬cAMP signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬39. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
41 | cAMP signaling pathway 💬 66 genes, 189 drugs (DrugBank) and 130 diseases |
EDNRA [1] EDNRA 💬cAMP signaling pathway
|
Macitentan Macitentan 💬cAMP signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬41. cAMP signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
42 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
CACNA1D [1] CACNA1D 💬Carbohydrate digestion and absorption
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Carbohydrate digestion and absorption
| Diltiazem | 051 [4] 51, 58, 86, 88 💬42. Carbohydrate digestion and absorption |
||||||||||||||||||||||||||||||||||||||||||||||||||
43 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
CACNA1D [1] CACNA1D 💬Carbohydrate digestion and absorption
|
Diltiazem malate Diltiazem malate 💬Carbohydrate digestion and absorption
| Diltiazem | 051 [4] 51, 58, 86, 88 💬42. Carbohydrate digestion and absorption |
||||||||||||||||||||||||||||||||||||||||||||||||||
44 | Carbohydrate digestion and absorption 💬 13 genes, 21 drugs (DrugBank) and 33 diseases |
CACNA1D [1] CACNA1D 💬Carbohydrate digestion and absorption
|
Diltiazem Diltiazem 💬Carbohydrate digestion and absorption
| Diltiazem | 051 [4] 51, 58, 86, 88 💬42. Carbohydrate digestion and absorption |
||||||||||||||||||||||||||||||||||||||||||||||||||
45 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Cardiac muscle contraction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬45. Cardiac muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||||||
46 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Cardiac muscle contraction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬45. Cardiac muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||||||
47 | Cardiac muscle contraction 💬 17 genes, 20 drugs (DrugBank) and 25 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Cardiac muscle contraction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬45. Cardiac muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||||||
48 | Cell cycle 💬 11 genes, 12 drugs (DrugBank) and 25 diseases |
ABL1 [1] ABL1 💬Cell cycle
|
Imatinib mesylate Imatinib mesylate 💬Cell cycle
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬48. Cell cycle
|
||||||||||||||||||||||||||||||||||||||||||||||||||
49 | Cell cycle 💬 11 genes, 12 drugs (DrugBank) and 25 diseases |
ABL1 [1] ABL1 💬Cell cycle
|
Imatinib Imatinib 💬Cell cycle
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬48. Cell cycle
|
||||||||||||||||||||||||||||||||||||||||||||||||||
50 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
CACNA1D [1] CACNA1D 💬Cellular senescence
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Cellular senescence
| Diltiazem | 051 [4] 51, 58, 86, 88 💬50. Cellular senescence |
||||||||||||||||||||||||||||||||||||||||||||||||||
51 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
CACNA1D [1] CACNA1D 💬Cellular senescence
|
Diltiazem malate Diltiazem malate 💬Cellular senescence
| Diltiazem | 051 [4] 51, 58, 86, 88 💬50. Cellular senescence |
||||||||||||||||||||||||||||||||||||||||||||||||||
52 | Cellular senescence 💬 34 genes, 46 drugs (DrugBank) and 96 diseases |
CACNA1D [1] CACNA1D 💬Cellular senescence
|
Diltiazem Diltiazem 💬Cellular senescence
| Diltiazem | 051 [4] 51, 58, 86, 88 💬50. Cellular senescence |
||||||||||||||||||||||||||||||||||||||||||||||||||
53 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Central carbon metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
54 | Central carbon metabolism in cancer 💬 19 genes, 37 drugs (DrugBank) and 65 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Central carbon metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬53. Central carbon metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
55 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬cGMP-PKG signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬55. cGMP-PKG signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
56 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬cGMP-PKG signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬55. cGMP-PKG signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
57 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬cGMP-PKG signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬55. cGMP-PKG signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
58 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [1] EDNRA 💬cGMP-PKG signaling pathway
|
Ambrisentan Ambrisentan 💬cGMP-PKG signaling pathway
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬58. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
59 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬59. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
60 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬cGMP-PKG signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬59. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
61 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬cGMP-PKG signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬61. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
62 | cGMP-PKG signaling pathway 💬 49 genes, 132 drugs (DrugBank) and 124 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬cGMP-PKG signaling pathway
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬62. cGMP-PKG signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
63 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
ABL1 [1] ABL1 💬Chemical carcinogenesis - reactive oxygen species
|
Imatinib mesylate Imatinib mesylate 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬63. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||
64 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
ABL1 [1] ABL1 💬Chemical carcinogenesis - reactive oxygen species
|
Imatinib Imatinib 💬Chemical carcinogenesis - reactive oxygen species
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬63. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||
65 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
NQO1 [1] NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin sodium Warfarin sodium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬65. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||
66 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
NQO1 [1] NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin potassium Warfarin potassium 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬65. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||
67 | Chemical carcinogenesis - reactive oxygen species 💬 25 genes, 39 drugs (DrugBank) and 51 diseases |
NQO1 [1] NQO1 💬Chemical carcinogenesis - reactive oxygen species
|
Warfarin Warfarin 💬Chemical carcinogenesis - reactive oxygen species
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬65. Chemical carcinogenesis - reactive oxygen species
|
||||||||||||||||||||||||||||||||||||||||||||||||||
68 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Chemical carcinogenesis - receptor activation
| Diltiazem | 051 [4] 51, 58, 86, 88 💬68. Chemical carcinogenesis - receptor activation |
||||||||||||||||||||||||||||||||||||||||||||||||||
69 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Chemical carcinogenesis - receptor activation
| Diltiazem | 051 [4] 51, 58, 86, 88 💬68. Chemical carcinogenesis - receptor activation |
||||||||||||||||||||||||||||||||||||||||||||||||||
70 | Chemical carcinogenesis - receptor activation 💬 39 genes, 135 drugs (DrugBank) and 134 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Chemical carcinogenesis - receptor activation
| Diltiazem | 051 [4] 51, 58, 86, 88 💬68. Chemical carcinogenesis - receptor activation |
||||||||||||||||||||||||||||||||||||||||||||||||||
71 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PDGFRA [1] PDGFRA 💬Choline metabolism in cancer
|
Imatinib mesylate Imatinib mesylate 💬Choline metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬71. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
72 | Choline metabolism in cancer 💬 11 genes, 30 drugs (DrugBank) and 61 diseases |
PDGFRA [1] PDGFRA 💬Choline metabolism in cancer
|
Imatinib Imatinib 💬Choline metabolism in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬71. Choline metabolism in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
73 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Cholinergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬73. Cholinergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
74 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Cholinergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬73. Cholinergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
75 | Cholinergic synapse 💬 32 genes, 64 drugs (DrugBank) and 81 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Cholinergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬73. Cholinergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
76 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
ABL1 [1] ABL1 💬Chronic myeloid leukemia
|
Imatinib mesylate Imatinib mesylate 💬Chronic myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬76. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||
77 | Chronic myeloid leukemia 💬 17 genes, 23 drugs (DrugBank) and 36 diseases |
ABL1 [1] ABL1 💬Chronic myeloid leukemia
|
Imatinib Imatinib 💬Chronic myeloid leukemia
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬76. Chronic myeloid leukemia
|
||||||||||||||||||||||||||||||||||||||||||||||||||
78 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Circadian entrainment
| Diltiazem | 051 [4] 51, 58, 86, 88 💬78. Circadian entrainment |
||||||||||||||||||||||||||||||||||||||||||||||||||
79 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem malate Diltiazem malate 💬Circadian entrainment
| Diltiazem | 051 [4] 51, 58, 86, 88 💬78. Circadian entrainment |
||||||||||||||||||||||||||||||||||||||||||||||||||
80 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem Diltiazem 💬Circadian entrainment
| Diltiazem | 051 [4] 51, 58, 86, 88 💬78. Circadian entrainment |
||||||||||||||||||||||||||||||||||||||||||||||||||
81 | Circadian entrainment 💬 23 genes, 39 drugs (DrugBank) and 55 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Circadian entrainment
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬81. Circadian entrainment
|
||||||||||||||||||||||||||||||||||||||||||||||||||
82 | Complement and coagulation cascades 💬 22 genes, 45 drugs (DrugBank) and 52 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Edoxaban tosilate hydrate Edoxaban tosilate hydrate 💬Complement and coagulation cascades
| Edoxaban | 046 [2] 46, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
83 | Complement and coagulation cascades 💬 22 genes, 45 drugs (DrugBank) and 52 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Edoxaban Edoxaban 💬Complement and coagulation cascades
| Edoxaban | 046 [2] 46, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
84 | Complement and coagulation cascades 💬 22 genes, 45 drugs (DrugBank) and 52 diseases |
F10 [1] F10 💬Complement and coagulation cascades
|
Edoxaban tosylate Edoxaban tosylate 💬Complement and coagulation cascades
| Edoxaban | 046 [2] 46, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
85 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Cortisol synthesis and secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬85. Cortisol synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
86 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Cortisol synthesis and secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬85. Cortisol synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
87 | Cortisol synthesis and secretion 💬 15 genes, 36 drugs (DrugBank) and 63 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Cortisol synthesis and secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬85. Cortisol synthesis and secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
88 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Cushing syndrome
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
89 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Cushing syndrome
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
90 | Cushing syndrome 💬 24 genes, 55 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Cushing syndrome
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
91 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Dilated cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬91. Dilated cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
92 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Dilated cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬91. Dilated cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
93 | Dilated cardiomyopathy 💬 24 genes, 61 drugs (DrugBank) and 88 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Dilated cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬91. Dilated cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
94 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Dopaminergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬94. Dopaminergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
95 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem malate Diltiazem malate 💬Dopaminergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬94. Dopaminergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
96 | Dopaminergic synapse 💬 31 genes, 102 drugs (DrugBank) and 104 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem Diltiazem 💬Dopaminergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬94. Dopaminergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
97 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
PDGFRA [1] PDGFRA 💬Endocytosis
|
Imatinib mesylate Imatinib mesylate 💬Endocytosis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬97. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
98 | Endocytosis 💬 22 genes, 37 drugs (DrugBank) and 54 diseases |
PDGFRA [1] PDGFRA 💬Endocytosis
|
Imatinib Imatinib 💬Endocytosis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬97. Endocytosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
99 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
ABL1 [1] ABL1 💬ErbB signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬ErbB signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬99. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
100 | ErbB signaling pathway 💬 14 genes, 28 drugs (DrugBank) and 62 diseases |
ABL1 [1] ABL1 💬ErbB signaling pathway
|
Imatinib Imatinib 💬ErbB signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬99. ErbB signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
101 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
NQO1 [1] NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin sodium Warfarin sodium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬101. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
102 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
NQO1 [1] NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin potassium Warfarin potassium 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬101. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
103 | Fluid shear stress and atherosclerosis 💬 34 genes, 59 drugs (DrugBank) and 93 diseases |
NQO1 [1] NQO1 💬Fluid shear stress and atherosclerosis
|
Warfarin Warfarin 💬Fluid shear stress and atherosclerosis
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬101. Fluid shear stress and atherosclerosis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
104 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PDGFRA [1] PDGFRA 💬Focal adhesion
|
Imatinib mesylate Imatinib mesylate 💬Focal adhesion
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬104. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
105 | Focal adhesion 💬 31 genes, 51 drugs (DrugBank) and 52 diseases |
PDGFRA [1] PDGFRA 💬Focal adhesion
|
Imatinib Imatinib 💬Focal adhesion
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬104. Focal adhesion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
106 | GABAergic synapse 💬 29 genes, 43 drugs (DrugBank) and 55 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬GABAergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬106. GABAergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
107 | GABAergic synapse 💬 29 genes, 43 drugs (DrugBank) and 55 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬GABAergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬106. GABAergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
108 | GABAergic synapse 💬 29 genes, 43 drugs (DrugBank) and 55 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬GABAergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬106. GABAergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
109 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Gap junction
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬109. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
110 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
PDGFRA [1] PDGFRA 💬Gap junction
|
Imatinib mesylate Imatinib mesylate 💬Gap junction
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬110. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
111 | Gap junction 💬 26 genes, 97 drugs (DrugBank) and 82 diseases |
PDGFRA [1] PDGFRA 💬Gap junction
|
Imatinib Imatinib 💬Gap junction
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬110. Gap junction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
112 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PDGFRA [1] PDGFRA 💬Glioma
|
Imatinib mesylate Imatinib mesylate 💬Glioma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬112. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
113 | Glioma 💬 15 genes, 34 drugs (DrugBank) and 64 diseases |
PDGFRA [1] PDGFRA 💬Glioma
|
Imatinib Imatinib 💬Glioma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬112. Glioma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
114 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Glutamatergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬114. Glutamatergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
115 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem malate Diltiazem malate 💬Glutamatergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬114. Glutamatergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
116 | Glutamatergic synapse 💬 23 genes, 30 drugs (DrugBank) and 81 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem Diltiazem 💬Glutamatergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬114. Glutamatergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
117 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬GnRH secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
118 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬GnRH secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
119 | GnRH secretion 💬 22 genes, 47 drugs (DrugBank) and 56 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬GnRH secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
120 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬GnRH signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬120. GnRH signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
121 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬GnRH signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬120. GnRH signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
122 | GnRH signaling pathway 💬 16 genes, 40 drugs (DrugBank) and 42 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬GnRH signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬120. GnRH signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
123 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Growth hormone synthesis, secretion and action
| Diltiazem | 051 [4] 51, 58, 86, 88 💬123. Growth hormone synthesis, secretion and action |
||||||||||||||||||||||||||||||||||||||||||||||||||
124 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Growth hormone synthesis, secretion and action
| Diltiazem | 051 [4] 51, 58, 86, 88 💬123. Growth hormone synthesis, secretion and action |
||||||||||||||||||||||||||||||||||||||||||||||||||
125 | Growth hormone synthesis, secretion and action 💬 23 genes, 49 drugs (DrugBank) and 100 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Growth hormone synthesis, secretion and action
| Diltiazem | 051 [4] 51, 58, 86, 88 💬123. Growth hormone synthesis, secretion and action |
||||||||||||||||||||||||||||||||||||||||||||||||||
126 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
KIT [1] KIT 💬Hematopoietic cell lineage
|
Imatinib mesylate Imatinib mesylate 💬Hematopoietic cell lineage
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬126. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||
127 | Hematopoietic cell lineage 💬 53 genes, 95 drugs (DrugBank) and 101 diseases |
KIT [1] KIT 💬Hematopoietic cell lineage
|
Imatinib Imatinib 💬Hematopoietic cell lineage
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬126. Hematopoietic cell lineage
|
||||||||||||||||||||||||||||||||||||||||||||||||||
128 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
NQO1 [1] NQO1 💬Hepatocellular carcinoma
|
Warfarin sodium Warfarin sodium 💬Hepatocellular carcinoma
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬128. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
129 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
NQO1 [1] NQO1 💬Hepatocellular carcinoma
|
Warfarin potassium Warfarin potassium 💬Hepatocellular carcinoma
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬128. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
130 | Hepatocellular carcinoma 💬 21 genes, 32 drugs (DrugBank) and 67 diseases |
NQO1 [1] NQO1 💬Hepatocellular carcinoma
|
Warfarin Warfarin 💬Hepatocellular carcinoma
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬128. Hepatocellular carcinoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
131 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PDGFRA [1] PDGFRA 💬Human cytomegalovirus infection
|
Imatinib mesylate Imatinib mesylate 💬Human cytomegalovirus infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬131. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
132 | Human cytomegalovirus infection 💬 64 genes, 114 drugs (DrugBank) and 130 diseases |
PDGFRA [1] PDGFRA 💬Human cytomegalovirus infection
|
Imatinib Imatinib 💬Human cytomegalovirus infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬131. Human cytomegalovirus infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
133 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Hypertrophic cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬133. Hypertrophic cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
134 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Hypertrophic cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬133. Hypertrophic cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
135 | Hypertrophic cardiomyopathy 💬 27 genes, 57 drugs (DrugBank) and 90 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Hypertrophic cardiomyopathy
| Diltiazem | 051 [4] 51, 58, 86, 88 💬133. Hypertrophic cardiomyopathy |
||||||||||||||||||||||||||||||||||||||||||||||||||
136 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Insulin secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬136. Insulin secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
137 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Insulin secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬136. Insulin secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
138 | Insulin secretion 💬 15 genes, 48 drugs (DrugBank) and 51 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Insulin secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬136. Insulin secretion |
||||||||||||||||||||||||||||||||||||||||||||||||||
139 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PDGFRA [1] PDGFRA 💬JAK-STAT signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬JAK-STAT signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬139. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
140 | JAK-STAT signaling pathway 💬 61 genes, 113 drugs (DrugBank) and 123 diseases |
PDGFRA [1] PDGFRA 💬JAK-STAT signaling pathway
|
Imatinib Imatinib 💬JAK-STAT signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬139. JAK-STAT signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
141 | Long-term depression 💬 14 genes, 23 drugs (DrugBank) and 34 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Long-term depression
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬141. Long-term depression
|
||||||||||||||||||||||||||||||||||||||||||||||||||
142 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
CACNA1C [1] CACNA1C 💬Long-term potentiation
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Long-term potentiation
| Diltiazem | 051 [4] 51, 58, 86, 88 💬142. Long-term potentiation |
||||||||||||||||||||||||||||||||||||||||||||||||||
143 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
CACNA1C [1] CACNA1C 💬Long-term potentiation
|
Diltiazem malate Diltiazem malate 💬Long-term potentiation
| Diltiazem | 051 [4] 51, 58, 86, 88 💬142. Long-term potentiation |
||||||||||||||||||||||||||||||||||||||||||||||||||
144 | Long-term potentiation 💬 18 genes, 36 drugs (DrugBank) and 86 diseases |
CACNA1C [1] CACNA1C 💬Long-term potentiation
|
Diltiazem Diltiazem 💬Long-term potentiation
| Diltiazem | 051 [4] 51, 58, 86, 88 💬142. Long-term potentiation |
||||||||||||||||||||||||||||||||||||||||||||||||||
145 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬MAPK signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬145. MAPK signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
146 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬MAPK signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬145. MAPK signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
147 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬MAPK signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬145. MAPK signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
148 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬MAPK signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬148. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
149 | MAPK signaling pathway 💬 65 genes, 98 drugs (DrugBank) and 109 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬MAPK signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬148. MAPK signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
150 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬150. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
151 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Bosentan Bosentan 💬Melanogenesis
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬150. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
152 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
EDNRB [1] EDNRB 💬Melanogenesis
|
Macitentan Macitentan 💬Melanogenesis
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬152. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
153 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
KIT [1] KIT 💬Melanogenesis
|
Imatinib mesylate Imatinib mesylate 💬Melanogenesis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬153. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
154 | Melanogenesis 💬 7 genes, 19 drugs (DrugBank) and 34 diseases |
KIT [1] KIT 💬Melanogenesis
|
Imatinib Imatinib 💬Melanogenesis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬153. Melanogenesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
155 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PDGFRA [1] PDGFRA 💬Melanoma
|
Imatinib mesylate Imatinib mesylate 💬Melanoma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬155. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
156 | Melanoma 💬 17 genes, 34 drugs (DrugBank) and 42 diseases |
PDGFRA [1] PDGFRA 💬Melanoma
|
Imatinib Imatinib 💬Melanoma
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬155. Melanoma
|
||||||||||||||||||||||||||||||||||||||||||||||||||
157 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
ABL1 [2] ABL1, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬MicroRNAs in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬157. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
158 | MicroRNAs in cancer 💬 33 genes, 75 drugs (DrugBank) and 90 diseases |
ABL1 [2] ABL1, PDGFRA 💬
|
Imatinib Imatinib 💬MicroRNAs in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬157. MicroRNAs in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
159 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [1] EDNRA 💬Neuroactive ligand-receptor interaction
|
Ambrisentan Ambrisentan 💬Neuroactive ligand-receptor interaction
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬159. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
160 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬160. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
161 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Neuroactive ligand-receptor interaction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬160. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
162 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Neuroactive ligand-receptor interaction
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬162. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
163 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Selexipag Selexipag 💬Neuroactive ligand-receptor interaction
| Selexipag | 047 [6] 47, 51, 70, 84, 86, 88 💬163. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
164 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil Treprostinil 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬164. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
165 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬164. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
166 | Neuroactive ligand-receptor interaction 💬 158 genes, 364 drugs (DrugBank) and 173 diseases |
PTGIR [1] PTGIR 💬Neuroactive ligand-receptor interaction
|
Treprostinil diolamine Treprostinil diolamine 💬Neuroactive ligand-receptor interaction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬164. Neuroactive ligand-receptor interaction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
167 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
ABL1 [1] ABL1 💬Neurotrophin signaling pathway
|
Imatinib mesylate Imatinib mesylate 💬Neurotrophin signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬167. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
168 | Neurotrophin signaling pathway 💬 22 genes, 29 drugs (DrugBank) and 37 diseases |
ABL1 [1] ABL1 💬Neurotrophin signaling pathway
|
Imatinib Imatinib 💬Neurotrophin signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬167. Neurotrophin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
169 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Oxytocin signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬169. Oxytocin signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
170 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Oxytocin signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬169. Oxytocin signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
171 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Oxytocin signaling pathway
| Diltiazem | 051 [4] 51, 58, 86, 88 💬169. Oxytocin signaling pathway |
||||||||||||||||||||||||||||||||||||||||||||||||||
172 | Oxytocin signaling pathway 💬 35 genes, 80 drugs (DrugBank) and 110 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Oxytocin signaling pathway
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬172. Oxytocin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
173 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
ABL1 [1] ABL1 💬Pathogenic Escherichia coli infection
|
Imatinib mesylate Imatinib mesylate 💬Pathogenic Escherichia coli infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬173. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
174 | Pathogenic Escherichia coli infection 💬 28 genes, 43 drugs (DrugBank) and 78 diseases |
ABL1 [1] ABL1 💬Pathogenic Escherichia coli infection
|
Imatinib Imatinib 💬Pathogenic Escherichia coli infection
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬173. Pathogenic Escherichia coli infection
|
||||||||||||||||||||||||||||||||||||||||||||||||||
175 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Pathways in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬175. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
176 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Pathways in cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬175. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
177 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [1] EDNRA 💬Pathways in cancer
|
Ambrisentan Ambrisentan 💬Pathways in cancer
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬177. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
178 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬178. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
179 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Bosentan Bosentan 💬Pathways in cancer
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬178. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
180 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
EDNRA [2] EDNRA, EDNRB 💬
|
Macitentan Macitentan 💬Pathways in cancer
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬180. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
181 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
NQO1 [1] NQO1 💬Pathways in cancer
|
Warfarin sodium Warfarin sodium 💬Pathways in cancer
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
182 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
NQO1 [1] NQO1 💬Pathways in cancer
|
Warfarin potassium Warfarin potassium 💬Pathways in cancer
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
183 | Pathways in cancer 💬 111 genes, 222 drugs (DrugBank) and 146 diseases |
NQO1 [1] NQO1 💬Pathways in cancer
|
Warfarin Warfarin 💬Pathways in cancer
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬181. Pathways in cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
184 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Pathways of neurodegeneration - multiple diseases
| Diltiazem | 051 [4] 51, 58, 86, 88 💬184. Pathways of neurodegeneration - multiple diseases |
||||||||||||||||||||||||||||||||||||||||||||||||||
185 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Pathways of neurodegeneration - multiple diseases
| Diltiazem | 051 [4] 51, 58, 86, 88 💬184. Pathways of neurodegeneration - multiple diseases |
||||||||||||||||||||||||||||||||||||||||||||||||||
186 | Pathways of neurodegeneration - multiple diseases 💬 63 genes, 138 drugs (DrugBank) and 132 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Pathways of neurodegeneration - multiple diseases
| Diltiazem | 051 [4] 51, 58, 86, 88 💬184. Pathways of neurodegeneration - multiple diseases |
||||||||||||||||||||||||||||||||||||||||||||||||||
187 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Phospholipase D signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬187. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
188 | Phospholipase D signaling pathway 💬 23 genes, 59 drugs (DrugBank) and 82 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Phospholipase D signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬187. Phospholipase D signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
189 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬PI3K-Akt signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬189. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
190 | PI3K-Akt signaling pathway 💬 85 genes, 142 drugs (DrugBank) and 131 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬PI3K-Akt signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬189. PI3K-Akt signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
191 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Platelet activation
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬191. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
192 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Selexipag Selexipag 💬Platelet activation
| Selexipag | 047 [6] 47, 51, 70, 84, 86, 88 💬192. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
193 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil Treprostinil 💬Platelet activation
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬193. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
194 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Platelet activation
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬193. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
195 | Platelet activation 💬 25 genes, 67 drugs (DrugBank) and 64 diseases |
PTGIR [1] PTGIR 💬Platelet activation
|
Treprostinil diolamine Treprostinil diolamine 💬Platelet activation
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬193. Platelet activation
|
||||||||||||||||||||||||||||||||||||||||||||||||||
196 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Prion disease
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
197 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Prion disease
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
198 | Prion disease 💬 41 genes, 74 drugs (DrugBank) and 114 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Prion disease
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
199 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PDGFRA [1] PDGFRA 💬Prostate cancer
|
Imatinib mesylate Imatinib mesylate 💬Prostate cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬199. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
200 | Prostate cancer 💬 24 genes, 57 drugs (DrugBank) and 89 diseases |
PDGFRA [1] PDGFRA 💬Prostate cancer
|
Imatinib Imatinib 💬Prostate cancer
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬199. Prostate cancer
|
||||||||||||||||||||||||||||||||||||||||||||||||||
201 | Purine metabolism 💬 30 genes, 40 drugs (DrugBank) and 73 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Purine metabolism
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬201. Purine metabolism
|
||||||||||||||||||||||||||||||||||||||||||||||||||
202 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Rap1 signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬202. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
203 | Rap1 signaling pathway 💬 45 genes, 113 drugs (DrugBank) and 98 diseases |
KIT [2] KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Rap1 signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬202. Rap1 signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
204 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib mesylate Imatinib mesylate 💬Ras signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬204. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
205 | Ras signaling pathway 💬 37 genes, 64 drugs (DrugBank) and 70 diseases |
ABL1 [3] ABL1, KIT, PDGFRA 💬
|
Imatinib Imatinib 💬Ras signaling pathway
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬204. Ras signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
206 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PDGFRA [1] PDGFRA 💬Regulation of actin cytoskeleton
|
Imatinib mesylate Imatinib mesylate 💬Regulation of actin cytoskeleton
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬206. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||
207 | Regulation of actin cytoskeleton 💬 35 genes, 82 drugs (DrugBank) and 81 diseases |
PDGFRA [1] PDGFRA 💬Regulation of actin cytoskeleton
|
Imatinib Imatinib 💬Regulation of actin cytoskeleton
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬206. Regulation of actin cytoskeleton
|
||||||||||||||||||||||||||||||||||||||||||||||||||
208 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬208. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
209 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Bosentan Bosentan 💬Relaxin signaling pathway
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬208. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
210 | Relaxin signaling pathway 💬 23 genes, 34 drugs (DrugBank) and 51 diseases |
EDNRB [1] EDNRB 💬Relaxin signaling pathway
|
Macitentan Macitentan 💬Relaxin signaling pathway
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬210. Relaxin signaling pathway
|
||||||||||||||||||||||||||||||||||||||||||||||||||
211 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Renin secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
212 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Renin secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
213 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Renin secretion
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
214 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Ambrisentan Ambrisentan 💬Renin secretion
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬214. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
215 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬215. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
216 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Bosentan Bosentan 💬Renin secretion
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬215. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
217 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
EDNRA [1] EDNRA 💬Renin secretion
|
Macitentan Macitentan 💬Renin secretion
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬217. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
218 | Renin secretion 💬 28 genes, 87 drugs (DrugBank) and 113 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Renin secretion
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬218. Renin secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
219 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Retrograde endocannabinoid signaling
| Diltiazem | 051 [4] 51, 58, 86, 88 💬219. Retrograde endocannabinoid signaling |
||||||||||||||||||||||||||||||||||||||||||||||||||
220 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Retrograde endocannabinoid signaling
| Diltiazem | 051 [4] 51, 58, 86, 88 💬219. Retrograde endocannabinoid signaling |
||||||||||||||||||||||||||||||||||||||||||||||||||
221 | Retrograde endocannabinoid signaling 💬 34 genes, 65 drugs (DrugBank) and 68 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Retrograde endocannabinoid signaling
| Diltiazem | 051 [4] 51, 58, 86, 88 💬219. Retrograde endocannabinoid signaling |
||||||||||||||||||||||||||||||||||||||||||||||||||
222 | Salivary secretion 💬 21 genes, 74 drugs (DrugBank) and 72 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Salivary secretion
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬222. Salivary secretion
|
||||||||||||||||||||||||||||||||||||||||||||||||||
223 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Serotonergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬223. Serotonergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
224 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Serotonergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬223. Serotonergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
225 | Serotonergic synapse 💬 39 genes, 122 drugs (DrugBank) and 83 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Serotonergic synapse
| Diltiazem | 051 [4] 51, 58, 86, 88 💬223. Serotonergic synapse |
||||||||||||||||||||||||||||||||||||||||||||||||||
226 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CACNA1C [1] CACNA1C 💬Taste transduction
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Taste transduction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬226. Taste transduction |
||||||||||||||||||||||||||||||||||||||||||||||||||
227 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CACNA1C [1] CACNA1C 💬Taste transduction
|
Diltiazem malate Diltiazem malate 💬Taste transduction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬226. Taste transduction |
||||||||||||||||||||||||||||||||||||||||||||||||||
228 | Taste transduction 💬 28 genes, 91 drugs (DrugBank) and 68 diseases |
CACNA1C [1] CACNA1C 💬Taste transduction
|
Diltiazem Diltiazem 💬Taste transduction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬226. Taste transduction |
||||||||||||||||||||||||||||||||||||||||||||||||||
229 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin calcium Atorvastatin calcium 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬229. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
230 | Terpenoid backbone biosynthesis 💬 4 genes, 14 drugs (DrugBank) and 56 diseases |
HMGCR [1] HMGCR 💬Terpenoid backbone biosynthesis
|
Atorvastatin Atorvastatin 💬Terpenoid backbone biosynthesis
| Atorvastatin | 013 [20] 13, 22, 46, 49, 51, 58, 63, 67, 79, 84, 88, 93, 96, 97, 160, 225, 265, 271, 297, 299 💬229. Terpenoid backbone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
231 | Tight junction 💬 13 genes, 36 drugs (DrugBank) and 50 diseases |
CACNA1D [1] CACNA1D 💬Tight junction
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Tight junction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
232 | Tight junction 💬 13 genes, 36 drugs (DrugBank) and 50 diseases |
CACNA1D [1] CACNA1D 💬Tight junction
|
Diltiazem malate Diltiazem malate 💬Tight junction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
233 | Tight junction 💬 13 genes, 36 drugs (DrugBank) and 50 diseases |
CACNA1D [1] CACNA1D 💬Tight junction
|
Diltiazem Diltiazem 💬Tight junction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬
|
||||||||||||||||||||||||||||||||||||||||||||||||||
234 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Type II diabetes mellitus
| Diltiazem | 051 [4] 51, 58, 86, 88 💬234. Type II diabetes mellitus |
||||||||||||||||||||||||||||||||||||||||||||||||||
235 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem malate Diltiazem malate 💬Type II diabetes mellitus
| Diltiazem | 051 [4] 51, 58, 86, 88 💬234. Type II diabetes mellitus |
||||||||||||||||||||||||||||||||||||||||||||||||||
236 | Type II diabetes mellitus 💬 14 genes, 42 drugs (DrugBank) and 94 diseases |
CACNA1C [2] CACNA1C, CACNA1D 💬
|
Diltiazem Diltiazem 💬Type II diabetes mellitus
| Diltiazem | 051 [4] 51, 58, 86, 88 💬234. Type II diabetes mellitus |
||||||||||||||||||||||||||||||||||||||||||||||||||
237 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 3 drugs (DrugBank) and 15 diseases |
NQO1 [2] NQO1, VKORC1 💬
|
Warfarin sodium Warfarin sodium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬237. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
238 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 3 drugs (DrugBank) and 15 diseases |
NQO1 [2] NQO1, VKORC1 💬
|
Warfarin potassium Warfarin potassium 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬237. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
239 | Ubiquinone and other terpenoid-quinone biosynthesis 💬 3 genes, 3 drugs (DrugBank) and 15 diseases |
NQO1 [2] NQO1, VKORC1 💬
|
Warfarin Warfarin 💬Ubiquinone and other terpenoid-quinone biosynthesis
| Warfarin | 006 [12] 6 , 8 , 19, 46, 49, 66, 85, 86, 88, 91, 96, 97 💬237. Ubiquinone and other terpenoid-quinone biosynthesis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
240 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem hydrochloride Diltiazem hydrochloride 💬Vascular smooth muscle contraction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬240. Vascular smooth muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||||||
241 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem malate Diltiazem malate 💬Vascular smooth muscle contraction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬240. Vascular smooth muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||||||
242 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
CACNA1C [4] CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬
|
Diltiazem Diltiazem 💬Vascular smooth muscle contraction
| Diltiazem | 051 [4] 51, 58, 86, 88 💬240. Vascular smooth muscle contraction |
||||||||||||||||||||||||||||||||||||||||||||||||||
243 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Ambrisentan Ambrisentan 💬Vascular smooth muscle contraction
| Ambrisentan | 051 [8] 51, 66, 84, 85, 86, 88, 210, 211 💬243. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
244 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
245 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Bosentan Bosentan 💬Vascular smooth muscle contraction
| Bosentan | 040 [11] 40, 41, 47, 51, 84, 85, 86, 88, 210, 211, 212 💬244. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
246 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
EDNRA [1] EDNRA 💬Vascular smooth muscle contraction
|
Macitentan Macitentan 💬Vascular smooth muscle contraction
| Macitentan | 051 [5] 51, 85, 86, 88, 210 💬246. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
247 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
GUCY1A [3] GUCY1A, GUCY1A, GUCY1B 💬
|
Riociguat Riociguat 💬Vascular smooth muscle contraction
| Riociguat | 051 [6] 51, 84, 86, 88, 225, 299 💬247. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
248 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Selexipag Selexipag 💬Vascular smooth muscle contraction
| Selexipag | 047 [6] 47, 51, 70, 84, 86, 88 💬248. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
249 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil Treprostinil 💬Vascular smooth muscle contraction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬249. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
250 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil monosodium salt Treprostinil monosodium salt 💬Vascular smooth muscle contraction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬249. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
251 | Vascular smooth muscle contraction 💬 32 genes, 92 drugs (DrugBank) and 71 diseases |
PTGIR [1] PTGIR 💬Vascular smooth muscle contraction
|
Treprostinil diolamine Treprostinil diolamine 💬Vascular smooth muscle contraction
| Treprostinil | 051 [5] 51, 85, 86, 88, 210 💬249. Vascular smooth muscle contraction
|
||||||||||||||||||||||||||||||||||||||||||||||||||
252 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
ABL1 [1] ABL1 💬Viral myocarditis
|
Imatinib mesylate Imatinib mesylate 💬Viral myocarditis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬252. Viral myocarditis
|
||||||||||||||||||||||||||||||||||||||||||||||||||
253 | Viral myocarditis 💬 34 genes, 27 drugs (DrugBank) and 52 diseases |
ABL1 [1] ABL1 💬Viral myocarditis
|
Imatinib Imatinib 💬Viral myocarditis
| Imatinib | 013 [12] 13, 28, 34, 35, 46, 51, 85, 86, 87, 88, 89, 162 💬252. Viral myocarditis
|
Acute myeloid leukemia
18 genes, 37 drugs (DrugBank) and 71 diseases
Adrenergic signaling in cardiomyocytes
31 genes, 84 drugs (DrugBank) and 76 diseases
Aldosterone synthesis and secretion
20 genes, 41 drugs (DrugBank) and 61 diseases
Alzheimer disease
59 genes, 132 drugs (DrugBank) and 129 diseases
Amphetamine addiction
25 genes, 58 drugs (DrugBank) and 92 diseases
AMPK signaling pathway
16 genes, 56 drugs (DrugBank) and 95 diseases
Arrhythmogenic right ventricular cardiomyopathy
15 genes, 30 drugs (DrugBank) and 28 diseases
Axon guidance
22 genes, 26 drugs (DrugBank) and 75 diseases
Bile secretion
14 genes, 36 drugs (DrugBank) and 61 diseases
Breast cancer
22 genes, 63 drugs (DrugBank) and 80 diseases
Calcium signaling pathway
86 genes, 214 drugs (DrugBank) and 143 diseases
cAMP signaling pathway
66 genes, 189 drugs (DrugBank) and 130 diseases
Carbohydrate digestion and absorption
13 genes, 21 drugs (DrugBank) and 33 diseases
Cardiac muscle contraction
17 genes, 20 drugs (DrugBank) and 25 diseases
Cell cycle
11 genes, 12 drugs (DrugBank) and 25 diseases
Cellular senescence
34 genes, 46 drugs (DrugBank) and 96 diseases
Central carbon metabolism in cancer
19 genes, 37 drugs (DrugBank) and 65 diseases
cGMP-PKG signaling pathway
49 genes, 132 drugs (DrugBank) and 124 diseases
Chemical carcinogenesis - reactive oxygen species
25 genes, 39 drugs (DrugBank) and 51 diseases
Chemical carcinogenesis - receptor activation
39 genes, 135 drugs (DrugBank) and 134 diseases
Choline metabolism in cancer
11 genes, 30 drugs (DrugBank) and 61 diseases
Cholinergic synapse
32 genes, 64 drugs (DrugBank) and 81 diseases
Chronic myeloid leukemia
17 genes, 23 drugs (DrugBank) and 36 diseases
Circadian entrainment
23 genes, 39 drugs (DrugBank) and 55 diseases
Complement and coagulation cascades
22 genes, 45 drugs (DrugBank) and 52 diseases
Cortisol synthesis and secretion
15 genes, 36 drugs (DrugBank) and 63 diseases
Cushing syndrome
24 genes, 55 drugs (DrugBank) and 71 diseases
Dilated cardiomyopathy
24 genes, 61 drugs (DrugBank) and 88 diseases
Dopaminergic synapse
31 genes, 102 drugs (DrugBank) and 104 diseases
Endocytosis
22 genes, 37 drugs (DrugBank) and 54 diseases
ErbB signaling pathway
14 genes, 28 drugs (DrugBank) and 62 diseases
Fluid shear stress and atherosclerosis
34 genes, 59 drugs (DrugBank) and 93 diseases
Focal adhesion
31 genes, 51 drugs (DrugBank) and 52 diseases
GABAergic synapse
29 genes, 43 drugs (DrugBank) and 55 diseases
Gap junction
26 genes, 97 drugs (DrugBank) and 82 diseases
Glioma
15 genes, 34 drugs (DrugBank) and 64 diseases
Glutamatergic synapse
23 genes, 30 drugs (DrugBank) and 81 diseases
GnRH secretion
22 genes, 47 drugs (DrugBank) and 56 diseases
GnRH signaling pathway
16 genes, 40 drugs (DrugBank) and 42 diseases
Growth hormone synthesis, secretion and action
23 genes, 49 drugs (DrugBank) and 100 diseases
Hematopoietic cell lineage
53 genes, 95 drugs (DrugBank) and 101 diseases
Hepatocellular carcinoma
21 genes, 32 drugs (DrugBank) and 67 diseases
Human cytomegalovirus infection
64 genes, 114 drugs (DrugBank) and 130 diseases
Hypertrophic cardiomyopathy
27 genes, 57 drugs (DrugBank) and 90 diseases
Insulin secretion
15 genes, 48 drugs (DrugBank) and 51 diseases
JAK-STAT signaling pathway
61 genes, 113 drugs (DrugBank) and 123 diseases
Long-term depression
14 genes, 23 drugs (DrugBank) and 34 diseases
Long-term potentiation
18 genes, 36 drugs (DrugBank) and 86 diseases
MAPK signaling pathway
65 genes, 98 drugs (DrugBank) and 109 diseases
Melanogenesis
7 genes, 19 drugs (DrugBank) and 34 diseases
Melanoma
17 genes, 34 drugs (DrugBank) and 42 diseases
MicroRNAs in cancer
33 genes, 75 drugs (DrugBank) and 90 diseases
Neuroactive ligand-receptor interaction
158 genes, 364 drugs (DrugBank) and 173 diseases
Neurotrophin signaling pathway
22 genes, 29 drugs (DrugBank) and 37 diseases
Oxytocin signaling pathway
35 genes, 80 drugs (DrugBank) and 110 diseases
Pathogenic Escherichia coli infection
28 genes, 43 drugs (DrugBank) and 78 diseases
Pathways in cancer
111 genes, 222 drugs (DrugBank) and 146 diseases
Pathways of neurodegeneration - multiple diseases
63 genes, 138 drugs (DrugBank) and 132 diseases
Phospholipase D signaling pathway
23 genes, 59 drugs (DrugBank) and 82 diseases
PI3K-Akt signaling pathway
85 genes, 142 drugs (DrugBank) and 131 diseases
Platelet activation
25 genes, 67 drugs (DrugBank) and 64 diseases
Prion disease
41 genes, 74 drugs (DrugBank) and 114 diseases
Prostate cancer
24 genes, 57 drugs (DrugBank) and 89 diseases
Purine metabolism
30 genes, 40 drugs (DrugBank) and 73 diseases
Rap1 signaling pathway
45 genes, 113 drugs (DrugBank) and 98 diseases
Ras signaling pathway
37 genes, 64 drugs (DrugBank) and 70 diseases
Regulation of actin cytoskeleton
35 genes, 82 drugs (DrugBank) and 81 diseases
Relaxin signaling pathway
23 genes, 34 drugs (DrugBank) and 51 diseases
Renin secretion
28 genes, 87 drugs (DrugBank) and 113 diseases
Retrograde endocannabinoid signaling
34 genes, 65 drugs (DrugBank) and 68 diseases
Salivary secretion
21 genes, 74 drugs (DrugBank) and 72 diseases
Serotonergic synapse
39 genes, 122 drugs (DrugBank) and 83 diseases
Taste transduction
28 genes, 91 drugs (DrugBank) and 68 diseases
Terpenoid backbone biosynthesis
4 genes, 14 drugs (DrugBank) and 56 diseases
Tight junction
13 genes, 36 drugs (DrugBank) and 50 diseases
Type II diabetes mellitus
14 genes, 42 drugs (DrugBank) and 94 diseases
Ubiquinone and other terpenoid-quinone biosynthesis
3 genes, 3 drugs (DrugBank) and 15 diseases
Vascular smooth muscle contraction
32 genes, 92 drugs (DrugBank) and 71 diseases
Viral myocarditis
34 genes, 27 drugs (DrugBank) and 52 diseases